Contact Us

About

To become the global leader in rapid brain diagnostics and reducing time to treatment

About Us

Revolutionising stroke diagnosis. Saving lives with accessible technology

UpFront Diagnostics was created to solve a critical problem: stroke subtypes often go undiagnosed when every minute matters. We set out bringing fast, accurate and accessible stroke diagnostics closer to the patient, improving the care pathway.

After years of research and collaboration with clinical experts, we developed LVOne, the world’s first rapid blood test to diagnose strokes. It delivers results in minutes, doesn’t need refrigeration and just uses a drop of capillary blood. This makes it ideal for use in ambulances, emergency rooms and remote settings.

Today, our mission is to equip healthcare teams with simple, reliable tools that help them act faster and save lives. We believe that stroke diagnosis should begin before the hospital, and with LVOne, that is now possible.

Our Vision and Mission

We deliver a life-saving solution for stroke detection

Vision

To become the global leader in rapid brain diagnostics and reducing time to treatment.

Mission

We simplify stroke diagnosis at the point of care by enabling faster indentification when every second matters.

20m
Potential Patients

Team

Global, Cross-Functional Teams Solve Complex Problems

Gonzalo Ladreda

CEO & Co-founder

Marcos Ladreda

Product Specialist & Co-founder

Dr. Joshua Bernstock

Chief Medical Officer

Dr. Edoardo Guade

Chief Scientific Officer & Co-founder

Dr. Tito Bacarese-Hamilton

Chairman

Francois Maisonrouge

Investor & Adviser

Karl Hick

Investor & NED

Ardashir Dubash

Investor & NED

Proprietary Biomarkers / Designed for emergency care/  Results within 10 minutes 
Proprietary Biomarkers / Designed for emergency care/  Results within 10 minutes 

Collaborators

We work with the world’s leading
collaborators to make this possible

Become a Distributor of the World’s First Lateral Flow Stroke Test

Download the exclusive LVOne Distributor Dossier to explore our breakthrough stroke diagnostic, its clinical validation, and the commercial opportunity in your region.

Downloads

Access our latest policies and
compliance documents

Carbon Reduction Plan 2026

Our commitment to achieving Net Zero emissions by 2045, including baseline emissions data and reduction targets.

Modern Slavery Policy

Our policy for prevention of modern slavery, outlining ethical sourcing principles and due diligence practices.